Similarly, AstraZeneca’s blockbuster drug Symbicort is only now facing a generic competitor, nearly 20 years after its 2006 launch. The inhaler has been widely prescribed because it contains a ...

Viatris' generic of Symbicort (budesonide and formoterol fumarate ... A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize ...

Symbicort was first FDA-approved ... and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy. Investigator sites are ...

Drug companies are taking advantage ... GlaxoSmithKline produce some of the most widely used inhalers in the United States, including Symbicort and Ventolin. They plan to seek regulatory approval ...

The inhaler cleared the FDA’s desk in ... Last August, Viatris and Kindeva Drug Delivery launched the first Symbicort copycat in the U.S. under the brand name Breyna. Breyna is indicated for ...

The clearance of Cipla's Goa facility opens the doors for the launch of Abraxane, which could be a around $120 million opportunity at peak.

Global Dyspnea Treatment MarketThe global dyspnea treatment market, valued at USD 5.90 billion in 2022, is expected to experience robust growth, projected to reach approximately USD 12.3 billion by ...

There are many types of asthma inhalers. They differ in whether they're used for quick relief or long-term control, what type of drug they contain, and how the medications are delivered to the lungs.

Any Australian who has filled a prescription at the chemist will have been asked if they want a branded product or the generic version. And with consumers looking to cut costs wherever they can ...